Stifel Financial Corp cut its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 6.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,137 shares of the company’s stock after selling 440 shares during the period. Stifel Financial Corp’s holdings in BlackRock Health Sciences Trust were worth $257,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in BME. Fountainhead AM LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 3rd quarter worth $204,000. Wolverine Asset Management LLC lifted its position in BlackRock Health Sciences Trust by 42.4% in the third quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock valued at $3,588,000 after buying an additional 25,457 shares during the last quarter. Consolidated Portfolio Review Corp increased its position in shares of BlackRock Health Sciences Trust by 7.2% during the third quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock valued at $1,785,000 after acquiring an additional 2,853 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of BlackRock Health Sciences Trust in the 3rd quarter valued at approximately $8,610,000. Finally, Logan Stone Capital LLC purchased a new stake in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at approximately $600,000.
BlackRock Health Sciences Trust Stock Down 0.4 %
NYSE:BME opened at $38.32 on Monday. BlackRock Health Sciences Trust has a fifty-two week low of $36.87 and a fifty-two week high of $42.86. The company has a 50 day moving average price of $39.50 and a 200 day moving average price of $40.68.
BlackRock Health Sciences Trust Dividend Announcement
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- What is Forex and How Does it Work?
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Retail Stocks Investing, Explained
- These 3 Quirky ETFs May Be Strong Plays in 2025
- What Makes a Stock a Good Dividend Stock?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.